Acquisition Of Infliximab 100 Mg Powder Inj (Biosimilar) Remsima - Pharmacovigilance

Name: Acquisition Of Infliximab 100 Mg Powder Inj (Biosimilar) Remsima - Pharmacovigilance
Start: 2024-03-30
End: -0001-11-30
Location: Centro Hospitalar Universitario Lisboa Central, E. P. E.

Centro Hospitalar Universitario Lisboa Central, E. P. E. Portugal has Released a tender for Acquisition Of Infliximab 100 Mg Powder Inj (Biosimilar) Remsima - Pharmacovigilance in Pharmaceuticals. The tender was released on Mar 29, 2024.

Country - Portugal

Summary - Acquisition Of Infliximab 100 Mg Powder Inj (Biosimilar) Remsima - Pharmacovigilance

Deadline - login to view

MT reference number - 80273910

Product classification - Pharmaceutical products

Organization Details:

Address - Portugal

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 80273910

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: ACQUISITION OF INFLIXIMAB 100 MG POWDER INJ (BIOSIMILAR) REMSIMA - PHARMACOVIGILANCE.additional_tender_url: https://www.base.gov.pt/Base4/pt/resultados/?type=doc_documentos&id=2119538&ext=.pdf.local title: AQUISIÇÃO DE INFLIXIMAB 100 M G PÓ INJ (BIOSSIMILAR) REMSIMA - FARMACOVIGILÂNCIA.netbudgeteuro: 145500.0.netbudgetlc: 145500.0.type_of_procedure: Other.bidding_response_method: Not Available

Mt Ref Id - 80273910

Deadline - Nov 30, -0001

View more tenders for

Pharmaceuticals Tenders Pharmaceutical products Tenders Portugal Tenders

Similar Tenders :

Most Searched